Credit Suisse Upgrades Enphase Energy to Outperform, Raises Price Target to $281
Credit Suisse analyst Maheep Mandloi upgrades Enphase Energy (NASDAQ:ENPH) from Neutral to Outperform and raises the price target from $174 to $281.
Why This Healthcare Stock Dipped Over 75%; Here Are 73 Biggest Movers From Yesterday
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 53.2% to close at $3.14 on Wednesday. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Children's Hospital Medical Center for S&P vaccine platform development.
This Asset Management Stock Is Trading Higher By More Than 45%, Here Are 54 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 67.8% to $3.4390. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Children's Hospital Medical Center for S&P vaccine platform development.
Enphase Energy Whale Trades Spotted
A whale with a lot of money to spend has taken a noticeably bearish stance on Enphase Energy.
Looking at options history for Enphase Energy (NASDAQ:ENPH) we detected 30 strange trades.
Needham Maintains Buy on Enphase Energy, Raises Price Target to $275
Needham analyst Vikram Bagri maintains Enphase Energy (NASDAQ:ENPH) with a Buy and raises the price target from $255 to $275.
Keybanc Maintains Overweight on Enphase Energy, Raises Price Target to $230
Keybanc analyst Sophie Karp maintains Enphase Energy (NASDAQ:ENPH) with a Overweight and raises the price target from $220 to $230.
Enphase Energy Q2 EPS $1.07 Beats $0.84 Estimate, Sales $530.20M Beat $504.53M Estimate
Enphase Energy (NASDAQ:ENPH) reported quarterly earnings of $1.07 per share which beat the analyst consensus estimate of $0.84 by 27.38 percent. This is a 101.89 percent increase over earnings of $0.53 per share from the